Grufity logoGrufity logo

Celanese Corp Stock Research

CE

104.36USD+2.05(+2.00%)Delayed

Market Summary

USD104.36+2.05
Delayed
2.00%

CE Alerts

CE Stock Price

CE RSI Chart

CE Valuation

Market Cap

11.3B

Price/Earnings (Trailing)

5.98

Price/Sales (Trailing)

1.18

EV/EBITDA

10.11

Price/Free Cashflow

8.87

CE Price/Sales (Trailing)

CE Profitability

EBT Margin

14.70%

Return on Equity

33.6%

Return on Assets

7.21%

Free Cashflow Yield

11.27%

CE Fundamentals

CE Revenue

Revenue Y/Y

1.54%

Revenue Q/Q

-7.44%

CE Earnings

Earnings (TTM)

1.9B

Earnings Y/Y

46.37%

Earnings Q/Q

301.57%

Price Action

52 Week Range

86.07159.25
(Low)(High)

Last 7 days

-13.3%

Last 30 days

-16.1%

Last 90 days

-0.1%

Trailing 12 Months

-24.8%

CE Financial Health

Current Ratio

1.63

Debt/Equity

2.37

Debt/Cashflow

0.14

CE Investor Care

Shares Dilution (1Y)

0.42%

Diluted EPS (TTM)

17.34

Peers (Alternatives to Celanese)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
34.6B
13.0B
-11.17% -4.61%
5.89
2.66
3.59% -9.26%
26.8B
17.7B
-2.11% 3.18%
24.98
1.52
5.06% -28.70%
25.1B
7.3B
-20.57% 18.26%
9.35
3.44
119.96% 2074.96%
11.3B
-
-16.10% -24.80%
5.98
1.18
22.25% 0.21%
MID-CAP
9.8B
10.6B
-9.42% -23.78%
12.4
0.93
0.99% -7.47%
6.9B
9.4B
-19.85% 0.94%
5.18
0.73
5.23% 2.33%
5.3B
4.9B
-4.95% 17.14%
26.11
1.1
10.60% -27.40%
5.1B
8.0B
-12.87% -28.62%
11.13
0.64
4.60% -55.98%
3.5B
3.4B
-2.52% -21.58%
5
1.04
2.46% 204.64%
2.4B
999.6M
1.27% 44.25%
215.39
2.37
3.34% -90.08%
SMALL-CAP
970.8M
1.9B
-18.23% -28.96%
5.65
0.5
15.49% 22.96%
703.1M
5.0B
-24.28% -54.90%
-1.63
0.14
2.86% -197.93%
412.9M
1.7B
-8.23% -1.55%
-27.68
0.24
22.00% -122.46%

Financials for Celanese

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-100.0%9,6009,5659,2778,537
Gross Profit-12.4%2,3802,7172,8862,9422,682
  S&GA Expenses13.7%824725706670633
  R&D Expenses14.3%11298.0094.0090.0086.00
EBITDA-15.8%2,2942,7242,8812,949-
EBITDA Margin-15.8%0.24*0.28*0.30*0.32*-
Earnings Before Taxes-31.1%1,4112,0482,3492,4552,248
EBT Margin-31.1%0.15*0.21*0.25*0.26*-
Interest Expenses57.0%40525812510191.00
Net Income14.7%1,8941,6511,9662,0701,890
Net Income Margin14.7%0.20*0.17*0.21*0.22*-
Free Cahsflow-1.8%1,2761,2991,4991,445-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets23.1%26,27221,33712,71312,42611,975
  Current Assets-49.9%6,61113,1924,4594,2003,807
    Cash Equivalents-84.4%1,5089,671783605536
  Inventory63.0%2,8081,7231,7131,5491,524
  Net PPE36.6%5,5844,0894,1584,1884,193
  Goodwill451.9%7,1421,2941,3481,3961,412
  Current Liabilities45.9%4,0682,7882,5952,5542,505
  Long Term Debt321.1%13,3733,176---
    LT Debt, Non Current275.9%11,3603,0223,1323,176-
Shareholder's Equity13.9%5,6374,9504,8804,6074,189
  Retained Earnings6.5%11,27410,58410,46610,1069,677
  Additional Paid-In Capital4.5%372356344326333
Accumulated Depreciation6.1%3,6873,4753,4973,5383,484
Shares Outstanding0.1%108108108108108
Minority Interest36.0%468344345346348
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-2.3%1,8191,8622,0251,9571,757
  Share Based Compensation-9.1%60.0066.0072.0098.0095.00
Cashflow From Investing-550.0%-11,141-1,714-1,679-1,366-1,119
Cashflow From Financing24.8%10,2908,247-581-766-1,042
  Dividend Payments1.0%297294297299304
  Buy Backs-92.1%17.002145007501,000

Risks for CE

What is the probability of a big loss on CE?

57.7%


Probability that Celanese stock will be more than 20% underwater in next one year

33.9%


Probability that Celanese stock will be more than 30% underwater in next one year.

28.9%


Probability that Celanese stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CE drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Celanese was unfortunately bought at previous high price.

Drawdowns

Returns for CE

Cumulative Returns on CE

10.2%


10-Year Cumulative Returns

8.9%


7-Year Cumulative Returns

1.2%


5-Year Cumulative Returns

11.5%


3-Year Cumulative Returns

What are the long-term rolling returns for CE?

FIve years rolling returns for Celanese.

Annualized Returns

Which funds bought or sold CE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
43.00
2,243,340
5,871,340
0.01%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-5.58
9,000
154,000
-%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
2,045
2,045
-%
2023-03-02
OLIVER LAGORE VANVALIN INVESTMENT GROUP
unchanged
-
396
4,396
-%
2023-02-28
Voya Investment Management LLC
reduced
-19.82
-421,286
4,126,710
0.01%
2023-02-27
ST GERMAIN D J CO INC
new
-
36,806
36,806
0.01%
2023-02-24
NATIXIS
reduced
-11.42
1,443
604,443
-%
2023-02-24
National Pension Service
unchanged
-
371,159
2,912,310
0.01%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
132
1,462,000
2,358,000
0.03%
2023-02-22
CVA Family Office, LLC
added
227
13,403
18,403
-%

1–10 of 48

Latest Funds Activity

Are funds buying CE calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CE
No. of Funds

Celanese News

MarketWatch

Celanese Corp. stock falls Friday, underperforms market.

MarketWatch,
20 hours ago

Moneyshow.com

Celanese: Chemical Powerhouse.

Moneyshow.com,
4 days ago

Zacks Investment Research

Zacks Investment Research

Schedule 13G FIlings of Celanese

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
dodge & cox
6.6%
7,109,524
SC 13G/A
Feb 14, 2023
berkshire hathaway inc
9.0%
9,710,183
SC 13G
Feb 09, 2023
vanguard group inc
12.30%
13,332,489
SC 13G/A
Feb 06, 2023
wellington management group llp
6.42%
6,961,945
SC 13G/A
Jan 31, 2023
blackrock inc.
7.0%
7,642,363
SC 13G
Feb 14, 2022
dodge & cox
6.6%
7,154,913
SC 13G/A
Feb 11, 2022
capital international investors
3.5%
3,842,948
SC 13G/A
Feb 09, 2022
vanguard group inc
12.33%
13,418,615
SC 13G/A
Feb 07, 2022
blackrock inc.
7.0%
7,642,373
SC 13G/A
Feb 04, 2022
wellington management group llp
8.67%
9,438,575
SC 13G/A

CE Fair Value

Celanese fair value in different scenarios

The table shows the Fair Value estimates for Celanese for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

264.49

153.44%

408.18

291.13%

685.80

557.15%

910.97

772.91%

1185.69

1036.15%
Current Inflation

242.19

132.07%

366.86

251.53%

602.16

477.00%

790.57

657.54%

1021.30

878.63%
Very High Inflation

214.67

105.70%

317.06

203.81%

504.08

383.02%

651.26

524.05%

832.59

697.81%

Historical Celanese Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Celanese

View All Filings
Date Filed Form Type Document
Mar 16, 2023
ARS/A
ARS/A
Mar 09, 2023
ARS
ARS
Mar 09, 2023
DEF 14A
DEF 14A
Mar 09, 2023
DEFA14A
DEFA14A
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading

Latest Insider Trading transactions for CE

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-28
Murray Mark Christopher
bought
140,580
117
1,200
svp - acetyls
2023-02-15
Richardson Scott A
acquired
-
-
19,292
evp & cfo
2023-02-15
Murray Mark Christopher
sold (taxes)
-15,073
121
-124
svp - acetyls
2023-02-15
Ryerkerk Lori
sold (taxes)
-2,913,910
121
-23,971
chairman and ceo
2023-02-15
Richardson Scott A
sold (taxes)
-973,817
121
-8,011
evp & cfo
2023-02-15
Kelly Thomas Francis
acquired
-
-
12,482
svp, em
2023-02-15
McGilvray Aaron M
sold (taxes)
-54,337
121
-447
chief accounting officer
2023-02-15
Puckett A. Lynne
acquired
-
-
12,482
svp, gc & sec
2023-02-15
Puckett A. Lynne
sold (taxes)
-716,718
121
-5,896
svp, gc & sec
2023-02-15
Kelly Thomas Francis
sold (taxes)
-575,708
121
-4,736
svp, em

1–10 of 50

Lori J. Ryerkerk
8530
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.

CE Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Net sales$ 9,673$ 8,537$ 5,655
Cost of sales(7,293)(5,855)(4,362)
Gross profit2,3802,6821,293
Selling, general and administrative expenses(824)(633)(482)
Amortization of intangible assets(62)(25)(22)
Research and development expenses(112)(86)(74)
Other (charges) gains, net(8)3(39)
Foreign exchange gain (loss), net(1)2(5)
Gain (loss) on disposition of businesses and assets, net53(7)
Operating profit (loss)1,3781,946664
Equity in net earnings (loss) of affiliates220146134
Non-operating pension and other postretirement employee benefit (expense) income1710617
Interest expense(405)(91)(109)
Refinancing expense0(9)0
Interest income6986
Dividend income - equity investments133147126
Gain (loss) on sale of investments in affiliates001,408
Other income (expense), net9(5)5
Earnings (loss) from continuing operations before tax1,4212,2482,251
Income tax (provision) benefit489(330)(247)
Earnings (loss) from continuing operations1,9101,9182,004
Earnings (loss) from operation of discontinued operations(9)(27)(14)
Income tax (provision) benefit from discontinued operations152
Earnings (loss) from discontinued operations(8)(22)(12)
Net earnings (loss)1,9021,8961,992
Net (earnings) loss attributable to noncontrolling interests(8)(6)(7)
Net earnings (loss) attributable to Celanese Corporation1,8941,8901,985
Amounts attributable to Celanese Corporation   
Earnings (loss) from continuing operations1,9021,9121,997
Earnings (loss) from discontinued operations(8)(22)(12)
Net earnings (loss) attributable to Celanese Corporation$ 1,894$ 1,890$ 1,985
Earnings (loss) per common share - basic   
Continuing operations$ 17.55$ 17.19$ 16.95
Discontinued operations(0.07)(0.20)(0.10)
Net earnings (loss) - basic17.4816.9916.85
Earnings (loss) per common share - diluted   
Continuing operations17.4117.0616.85
Discontinued operations(0.07)(0.20)(0.10)
Net earnings (loss) - diluted$ 17.34$ 16.86$ 16.75
Weighted average shares - basic108,380,082111,224,017117,817,445
Weighted average shares - diluted109,235,376112,084,412118,481,376

CE Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current Assets  
Cash and cash equivalents$ 1,508$ 536
Trade receivables - third party and affiliates1,3791,161
Non-trade receivables, net675506
Inventories2,8081,524
Other assets24180
Total current assets6,6113,807
Investments in affiliates1,062823
Property, plant and equipment (net of accumulated depreciation - 2022: $3,687; 2021: $3,484)5,5844,193
Operating lease right-of-use assets413236
Deferred income taxes808248
Other assets547521
Goodwill7,142[1]1,412
Intangible assets, net4,105735
Total assets26,27211,975
Current Liabilities  
Short-term borrowings and current installments of long-term debt - third party and affiliates1,306791
Trade payables - third party and affiliates1,5181,160
Other liabilities1,201473
Income taxes payable4381
Total current liabilities4,0682,505
Long-term debt, net of unamortized deferred financing costs13,3733,176
Deferred income taxes1,242555
Uncertain tax positions322280
Benefit obligations411558
Operating lease liabilities364200
Other liabilities387164
Commitments and Contingencies
Shareholders' Equity  
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2022 and 2021: 0 issued and outstanding)00
Common stock, $0.0001 par value, 400,000,000 shares authorized (2022: 170,135,425 issued and 108,473,932 outstanding; 2021: 169,760,024 issued and 108,023,735 outstanding)00
Treasury stock, at cost (2022: 61,661,493 shares; 2021: 61,736,289 shares)(5,491)(5,492)
Additional paid-in capital372333
Retained earnings11,2749,677
Accumulated other comprehensive income (loss), net(518)(329)
Total Celanese Corporation shareholders' equity5,6374,189
Noncontrolling interests468348
Total equity6,1054,537
Total liabilities and equity$ 26,272$ 11,975
[1]There were no accumulated impairment losses as of December 31, 2022.